Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand
Open Access
- 31 March 2004
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (3) , 156-170
- https://doi.org/10.1016/j.bbmt.2003.10.005
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34+ cellsBone Marrow Transplantation, 2003
- Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell ApoptosisThe Journal of Experimental Medicine, 2001
- Major histocompatibility complex–mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4+ donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesisBlood, 2001
- Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trialBone Marrow Transplantation, 1999
- PROMISCUOUS RECOGNITION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II DETERMINANTS IN CYCLOSPORINE-INDUCED SYNGENEIC GRAFT-VERSUS-HOST DISEASETransplantation, 1998
- Apoptosis by Death FactorCell, 1997
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Interferon-γ Potentiates the Antitumor Effect of Cyclosporine-Induced AutoimmunityJournal of Hematotherapy, 1992
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- T cell tolerance by clonal elimination in the thymusCell, 1987